Ayala Pharmaceuticals Inc (ADXS)

[equaloppforall]

Understood, Fbg. Just to add to my point though, ADXS should not compromise on AXAL at this point, since we hope to be the new standard of care for HPV related cancers, and that is not at all far fetched based on the data we have seen till date. While the shorts are able to deny ADXS its appropriate market cap, which I would reasonably put at around 2 billion at this point, there would be no denying its value once AXAL starts gaining early approvals in Europe and Asia. Dan knows it and all the potential negotiating partners know it. It would be in the larger company's interest to seal a solid deal before ADXS manages to materialize these goals, at which point Dan's leverage will only increase for an even sweeter deal.